Equine Canada has been advised by the Fédération Équestre Internationale (FEI) that it is investigating a sample from Canadian athlete Jonathon Millar, taken during a routine competition drug test.
Article 14.2 of the FEI’s Anti-Doping Rules for Human Athletes prohibit national equestrian federations from publicly commenting on the specific facts of a pending case, beyond matters of general process and science.
As is the FEI’s standard process, Mr. Millar has been placed on a provisional suspension while this matter is under investigation. He will participate in a provisional FEI hearing at a date to be set shortly.
“Jonathon is one of the gentlemen of our sport, and he has been co-operating fully with us,” said Akaash Maharaj, Chief Executive Officer of Equine Canada and the Canadian Equestrian Team. “Our first responsibility is to protect the integrity of the sport system, by upholding both the WADA code and the athlete’s right to a fair and impartial hearing. Accordingly, we are working closely with Jonathon and with the FEI to ensure that all the facts are made available during the hearings, to bring this matter to a just conclusion without delay.”